Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

RSS icon
Compensation for U.S. cardiologists is up across the board, according to a recent survey published by MedAxiom, an American College of Cardiology company. The report identified similar trends for cardiovascular surgeons, highlighting the country’s high demand for all heart specialists in 2024 and beyond.

Q&A: MedAxiom CEO explores key trends in cardiologist, cardiovascular surgeon compensation

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

patient engagement satisfaction

5 ways to let AI raise patient satisfaction, elevate provider performance

It’s been years since AI proponents started promising big returns on healthcare providers’ investments in the technology. The results have yet to catch up with the pitches. What’s the holdup? 

Police sidearm gun firearm

Texas AG sues hospital for $10K after off-duty police barred from carrying guns

Texas Attorney General Ken Paxton claims Memorial Hermann Health System violated a state law that authorizes any establishment serving the public to allow police officers to carry firearms, even if they’re dressed in civilian clothing. 

SCAI celebrated William W. O'Neill, MD, and Cindy L. Grines, MD, two veteran interventional cardiologists who played key roles guiding the development of primary percutaneous coronary intervention (PCI) as a treatment for ST-elevated myocardial infarction (STEMI) patients.

Cardiologists reflect on developing primary PCI in face of criticism and pushback

SCAI celebrated cardiologists William W. O'Neill, MD, and Cindy L. Grines, MD, for the important roles they played in the development of primary PCI. “It was challenging,” Grines explained. “We had the pharmaceutical industry that was anti-primary angioplasty and we had a lot of our own colleagues that were anti-primary angioplasty."

Federal Trade Comission FTC Sign logo

PBMs sue FTC for alleged Fifth Amendment violation

Caremark, Express Scripts and Optum Rx claim the FTC’s internal administrative court is unconstitutional. The agency sued the PBMs in September, claiming they engage in collusive business practices. 

Thumbnail

Asante Medical facing $488M in lawsuits after fentanyl diversion linked to 16 deaths

The nurse responsible has been charged with 44 counts of second-degree assault. Her criminal trial begins Dec. 30.

FDA issues Class I alert on Philips ventilators after 4 injuries

All serial numbers and lots of several Philips ventilators are at risk for damaged airflow sensors if used with in-line nebulizers.

Dr. Mehmet Oz, MD - The Dr. Oz Show

Trump selects Emmy-winning TV personality Dr. Oz to head CMS

President-elect Donald Trump announced the nomination of former "Dr. Oz Show" star Mehmet Oz just days after appointing Robert F. Kennedy Jr. as secretary of health. 

Displaying 57 - 64 of 8453

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.